Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Tim O'Brien, Keith Warner, Michael Henighan


DNAnexus has appointed Tim O'Brien as vice president of sales. He joins the company from Oracle's Health Sciences Global Business Unit, where he led the America's healthcare sales team. Previously, he held sales and sales management positions at IDBS, Infotrieve, and Life Technologies.

WaferGen has appointed Keith Warner as chief operating officer and Michael Henighan as chief financial officer.

Warner has served as a consultant to several life science investment firms since 2009 and was also previously vice president of worldwide marketing at Novartis/Chiron and CEO of Biodesix.

Henighan was a founder and CFO of Aplegen prior to joining WaferGen. Before that, he served as CFO or corporate controller at Alpha Innotech, HemoSense, and Cholestech.

The Scan

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.

New Oral Nanomedicine Strategy Targets Gut-Brain Axis to Treat IBD

A new paper in Science Advances describes a platform to design polyphenol-armored oral medicines that are effective at treating inflammatory bowel disease.

Phylogenetic Data Enables New Floristic Map

Researchers in Nature Communications use angiosperm phylogenetic data to refine the floristic regions of the world.

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.